1. Combined recombinant interferon alpha-2 and cytotoxic agents studies in clonogenic assay;Welander;Int J Cancer,1985
2. Rationale for and conduct of a phase I clinical trial with interferon alpha-2b plus doxorubicin;Von Hoff;Sem Oncol,1986
3. Interferon alpha-2b-cyclophosphamide combination studies: in vitro and phase I–II clinical results;Durie;Sem Oncol,1986
4. Intraperitoneal recombinant alpha interferon for “salvage” immunotherapy in stage II epithelial ovarian cancer: a gynecologic oncology group study;Berek;Cancer Res,1985
5. Superficial bladder cancers are responsive to alpha-2 interferon administration intravesically;Torti,1984